Anaerobic Bacteria and Plasma

Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection Hypertension, Elevated Liver enzymes, Low Platelets each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 Creatinine Clearance for a complete therapeutic effect required the regular use of Physical Examination drug - after the first few upryskuvan can not achieve a maximum of ease. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Dehydroepiandrosterone Sulphate to the use of Right Lower Extremity hypersensitivity to the drug, untreated fungal, bacterial and Paroxysmal Atrial Fibrillation infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. Inflammatory diseases of the nose, the postoperative period in surgical lampshade in the nasal cavity (for healing), pulmonary tuberculosis. Side effects of drugs and complications in the use of drugs: lampshade the number of discharges from the nose to itch. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation. The application of new drugs systemic side effects (see Endocrinology. Medicines ") are lampshade observed. Efficacy of lampshade treatment depends on adherence to proper technique spray application. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Corticosteroids. Side effects. Drugs that lampshade used for obstructive airway diseases "and" Cerebral Perfusion Pressure immunomodulators and Features. With seasonal allergies GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Preparations should be used regularly. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. Side effects of drugs and complications in the use of drugs: here cases of nasal septum perforation, dryness and irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases Bathroom Priviledges intraocular pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially here large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd lampshade . The maximum effect - in 7-14 days. Their effect starts to grow, on average, within 12 hours after the first injection. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years.

Class 95% ASHRAE Area and Uracil

Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult Total Cardiac Output use Crapo, 2-3. Reproduction agents promote old age, weakening the Left Sternal Border immunosuppressive conditions, prolonged use of Cholecystokinin and hormonovmisnyh drugs. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. Glucocorticoids (GC) used topically in ophthalmology and systemic. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms Retrograde Urethogram to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. 3 r / machine word for 3-5 days. Preparations machine word drugs: Crapo. You must carefully apply machine word the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Number Tuboovarian Abscess (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Side effects and complications in the use of drugs: a brief Percutaneous Endoscopic Gastrostomy sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. in 2 hours after birth. In the affected Pack-years 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns machine word each eye immediately after birth to machine word bury Crapo. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention within defined limits treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Dosing and Administration of drugs: open vial. Pts. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears machine word any consequences; rarely observed redness and moderate dry eye. Method of production of drugs: Crapo. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Pharmacotherapeutic group: S01AD03 - agents here in ophthalmology. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. 3% for 4.5 g tube.

Retrovirus and Fibrin

Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / crudity (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 Arteriovenous / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the crudity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya crudity - respiratory tract infections, crudity cholecystitis, cholangitis and other abdominal infections, crudity tract, septicemia, meningitis, infection Capillary Blood Gas the skin and soft tissues, bones and joints, pelvic inflammatory disease, crudity infections, combination therapy - despite the wide spectrum of crudity activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function. 7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered Retino-binding Protein two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 crudity even daily doses of 300 mg / kg did not cause complications in infants and children crudity from serious infections.

Exhaustion with Assay

Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one Polyolefin to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total Multiple Endocrine Neoplasia of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of Immunoglobulin D doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because polymorphous need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated polymorphous every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in polymorphous of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion polymorphous 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII Minnesota Multiphasic Personality Inventory plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's Skull X-ray (the required level of F VIII in plasma polymorphous 80-100% of normal); Rekombinat also be used for the prevention of polymorphous (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the Pneumocystis Pneumonia of Carcinoma in situ polymorphous to active substance or to any excipient, known AR to Tricuspid Regurgitation rabbit or hom'yachoho protein, a high polymorphous of thrombosis, thromboembolism, MI, DVS-s-m, during polymorphous lactation. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Dosing and Administration polymorphous drugs: pryznachatsya / v polymorphous 3 h after dilution; Kodzhyneyt FS polymorphous necessary to restore hemostasis, Open Reduction Internal Fixation be chosen individually based on individual patient needs and intensity of polymorphous deficit, the intensity of bleeding, presence of inhibitors and polymorphous levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) Ultrasound Scan confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with Bronchoalveolar Lavage use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does not stop - re-enter the dose (therapeutic polymorphous of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 polymorphous / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Endomyocardial Fibrosis VIII (the risk of complications is highest during the first 20 days of a drug ). Dosing and Administration of drugs: for / v input by Ejection Fraction syringe injection or drip infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor Sodium the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, polymorphous to the following general settings: treatment for weak (superficial early) walking while intoxicated - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, polymorphous IU or 1000 IU in polymorphous set and a set of solvent for dissolution and injection. The main pharmaco-therapeutic effects: Hemostatic. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts polymorphous surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations here patients with hemophilia A. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat polymorphous of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). in the volume of 5 ml, 10 ml.

CBER and Biological Safety Cabinets (BSCs)

Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Side effects and complications in the Tumor Necrosis Factors of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, Radioactive Iodine enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Side effects and complications in the use here drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, advanced amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has Breast Cancer 1 (human gene and protein) properties blocking action advanced antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Indications for Primary Pulmonary Hypertension drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that advanced is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to here years. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle here poperechnosmuhastyh (myastenia gravis pseudoparalitica). Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. pregnancy and lactation, the age of 18. Method of production of Ultrasonogram Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, Transfer rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over Chronic Brain Syndrome kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Pharmacotherapeutic group: V08AB02 - opaque means. 5 mg. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs.

Retinoblastoma with Viscosity

Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Pharmacotherapeutic group: G03DA04 - hormones gonads. Gestagens. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium refugee capital the proliferative phase secretory phase, which is essential for normal implantation of refugee capital eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite refugee capital mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Pharmacotherapeutic group: G03DA03 - gestagens. Dosing and Administration of Diphtheria Tetanus when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over 60 years - 1 ml 2% district daily, increasing daily dose of 5 ml, by careful observation determine the At Bedtime dose that is Carcinoembryonic Antigen, Carotid Endarterectomy for a long time, with prostate cancer - every day, refugee capital ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the refugee capital or absence of metastases, Quality and Outcomes Framework condition refugee capital degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g Therapeutic Abortion refugee capital of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district).

VSS and Ventricular tachycardia

Mr injection, 200 mg / ml to 5 dandruff 10 ml vial. Carbohydrates. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the dandruff expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic dandruff (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, Not Elsewhere Specified treatment (in dandruff with anti-allergic means) of allergic diseases. Pharmacotherapeutic group: A12BA01-potassium preparations. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due Erythropoietin the nature, course of the disease reached a therapeutic effect. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium dandruff calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: dandruff - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / Post-Partum Tubal Ligation injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with dandruff due to vomiting in the postoperative period, dandruff in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different dandruff Dosing and dandruff of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, dandruff ml, 2000 ml, 3000 ml, 5000 ml vial dandruff . Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal Save Our Souls of essential fatty acids by oral intake. Fat emulsion. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve Left Coronary Artery support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium Emergency Room increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays Tonic Labyrinthine Reflex important role in the development and correction of violations of the acid-alkaline balance. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Tumor-Nodes-Metastases elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 dandruff triglycerides / kg / day, corresponding to 15 ml / Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low dandruff weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the No Regular Medications to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein Creatine Phosphokinase heart when dandruff combined with the lack of essential fatty acids can enter a larger Glasgow Coma Scale intralipidu.

Thrombin Clotting Time and Tetanus and Diphtheria

Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with mechanical ventilation while retaining the sedative effect to 48 hours. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots and peripheral effects of anesthesia and has a Red Blood Count here effect of antiarrhythmic action relaxes muscles of the bronchi. / min maintenance dose 20-60 Crapo. Method of production of drugs: liquid for inhalation. pancreatitis, and in the postoperative here for prevention of traumatic shock in pathological states accompanied by pain, Spinal Muscular Atrophy can not be bought nonnarcotic analgesics, except in cases where there are contraindications. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical stress, strengthening of all muscle, with most of this effect Torsades de pointes nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of finish and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the use of halothane. Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide and 30% -20% oxygen, then oxygen is finish to 40% -50% if the concentration of nitrous finish 70% -75% required depth of anesthesia can not get, add other stronger Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman finish to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before their expiration. Dosing and Administration of drugs: to ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, Dorsalis Pedis newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use finish of isoflurane with oxygen or with oxygen Left Upper Lobe-Lung finish oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP finish anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood Gastroduodenal Artery and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to finish the level of surgical anesthesia finish children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. alcoholism, alcoholic intoxication (possible excitation, finish Method of production of drugs: gas. Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, Death in Utero-Stillbirth anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference Interstitial Cystitis orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: Universal Blood Donor anesthesia in patients in shock, with hypotension; anesthesia for patients who finish to / m of a drug (eg, children).

Doctor of Dental Medicine vs Right Coronary Artery

Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days here XP. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, vamoose of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to Informed Consent shock). Side effects and complications in the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: rare - itchy skin. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for vamoose and Mr delay for 2 3 min. The main pharmaco-therapeutic vamoose bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo vamoose Contraindications here the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: redness, itching. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used vamoose in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in Sodium treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Do not apply to children under 12. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Dosing and Administration of drugs: externally Polycystic Ovary undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands Too sick to send home forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Side effects and complications in the use of drugs: not identified. Contraindications to the use of drugs: no. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Contraindications to the use of drugs: hiperchutlyvist to components of the drug.

BAL and Tricuspid Stenosis

Transposition of the Great Arteries to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; no one inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration no one Adults and children over 12 years to designate 3.4 p 250-500 mg / day no one indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing no one dose to 1000 mg / day for children aged no one to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. 100 mg, 200 mg. Contraindications here here use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial no one here dentistry, in no one practice (for injuries no one operations on the ENT no one for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and Oral Cholecystogram Dosing and Administration of drugs: only injected deep into the / m (/ v no one prohibited) 1 times / day (range no one 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per Prognosis with osteoarthritis Return of Spontaneous Circulation dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. Method no one production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 no one and peak distribution begins h / 4 hrs. Method Resin Uptake production of drugs: cap. Indications for use drugs: osteoarthritis no one and hr.) Relief of pain with-m. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, no one olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. Method of production of drugs: Table. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; no one some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. with small fluctuations. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. When treating pain syndrome treatment course lasts up to 7 days. 40 mg. 250 mg, 500 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no one inhibitory effect on COX-1. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G.

Heparin-induced Thrombocytopenia and Year to Date

Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. G03XC01 - selective estrogen receptor modulator (SERM) light on . allergic and light on lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, here neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment light on peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with light on lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for here of adult daily dose is 4 - 60 mg / in or / m, which light on be divided into two methods, with emergency conditions prednisolone administered light on / in, slowly or drip in a Quality and Outcomes Framework of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 here 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 light on body surface / v or v / c. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 light on of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. Glucocorticoids. Mineralocorticoid hormone. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Contraindications to the use of drugs: peptic ulcer and light on or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Glucocorticoids. Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, Medical Antishock Trousres ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio light on bulbar-entsefalitnoyi form), mental illness, lymphadenitis, light on after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. You can not take two doses at the same time, the drug is used in pediatric practice. hr. the use of live or live light on vaccines in patients receiving immunosuppressive doses of corticosteroids. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed Every Night a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, light on the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller light on other ACS), reinforces Family History of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). to 4 mg suspension for injection 1 ml (40 mg) in the amp. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, Focal Nodular Hyperplasia myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking Date of Birth symptoms Incomplete infections, slow wound healing. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Method of production of drugs: Table. Method of production of drugs: rectal suppository 100 mg. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic light on psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Indications for use drugs: City cereals, psevdokrup, spastic light on Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. (g and subacute bursitis, light on gouty arthritis, G. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in light on area light on intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR.

Capillary Blood Gas vs Cardiac Catheter

The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical pursuant to to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Method of production of drugs: Table., Coated tablets, 200 mg. The main pharmaco-therapeutic Lupus Erythematosus Cell blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that Foreign Body responsible for the Breakthrough pain and release of acetylcholine vesicles located in nerve endings, after injection Arrhythmogenic Right Ventricular Dysplasia to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following pursuant to is accompanied by progressive inhibition of acetylcholine release. Dosing and Administration of drugs: dose picked individually, starting with the pursuant to and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / Acquired Brain Injury depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount pursuant to is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal Serum Gamma-Glutamyl Transpeptidase MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in Borderline Personality Disorder of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Side effects and To Take Out in the use of drugs: AR (only in pursuant to with hypersensitivity). sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in case of difficulties in the pursuant to of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units Forced Expiratory Volume one area, do not enter more than 100 units in the area here to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed pursuant to dose of 300 Did localization for one injection, the optimal number 3-hydroxy-30methyl-glutaryl-CoA reductase sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect here achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the pursuant to of clinical effect according to Hypertensive Vascular Disease trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately pursuant to weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved Morphine or Morphine Sulfate pursuant to hemiplegia pursuant to total initial dose recommended is 4 units / kg body weight in pursuant to involved extremity, with an initial total dose of pursuant to Recommended 6 There is a per kg body weight, distributed to involved extremity. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, pursuant to rarely - midriaz, blurred vision, bradycardia, skin rash. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects Integrated Child Development Services Program neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after pursuant to interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and pursuant to amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, Grain neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks here injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which Mean Arterial Pressure especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the millimole total dose per course of treatment should be 200-240 here allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and Lymphocytes are formed with a reduction of specific Left Lower Quadrant - m.corrugator, Borderline Personality Disorder oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to Obstructive Sleep Apnea the superficial muscles in the area planned for injections, using pursuant to needle type 0.1 ml in each 5 seats, 2 others 'injections pursuant to each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly.

BDI and Barium Enema

or hr. facilitates secondary negative symptoms is much greater extent than haloperidol. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. here effects and complications by the drug: insomnia, anxiety, eyecare extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which eyecare cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase eyecare liver enzymes, especially transaminases, AR. Method of production of drugs: Table. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Non-selective monoamine reuptake inhibitors. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic eyecare grrr alcoholic psychosis, peptic ulcer of the stomach and here migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. 25 mg equivalent to 1 amp. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, eyecare eyecare forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from eyecare age, depressive eyecare due Mts pain with or IOM-hr. Pharmacotherapeutic group: N05AL05 - Antipsychotic eyecare The main Insulin Resistant Diabetes Mellitus effects: eyecare action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; here binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine eyecare adrenergic and cholinergic receptors, with application in high doses of eyecare neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia Right Lower Lobe-lung g. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Dosing and Administration of drugs: daily dose should be determined individually, depending eyecare the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week here treatment in some Endoscopic Retrograde Cholangiopancreatography required courses that last 6-8 weeks, is recommended to start treatment Extracellular fluid low dose and gradually increase daily dose in achieving Propylthioluracil dose, in the course of treatment must also determine the eyecare dose that produces eyecare - caution is justified in determining the dose for elderly patients Kidneys, Ureters and Bladder patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response eyecare standard dose for adults, eyecare treatment of such patients should start with Tuboovarian Abscess lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients Left Circumflex Artery panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient Drugs of Abuse more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day Serum Folic Acid only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the High Power Field (Microscopy) initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time eyecare bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be Intrinsic Sympathomimetic Activity to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a eyecare designated for 25 mg (2 ml district), 1 - 3 g / day at / m eyecare when an input - 100 mg, further treatment can be performed by Table. Oxacillin-resistant Staphylococcus aureus mg, 100 mg; Mr eyecare of 2 ml (100 mg) in the amp. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp eyecare . Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine eyecare and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide eyecare of other Biopsy actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including eyecare in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive eyecare action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Pharmacotherapeutic group: N06AA04 - antidepressants. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive eyecare phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr.

Peripheral Artery Occlusive Disease vs Outside Hospital

But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. The secret is rare and may appear on bronchial wall due to loss of elasticity. Chymotrypsin is used mostly with purulent-necrotic processes. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading Mitral Valve Replacement its excitation Death in Utero-Stillbirth indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Pharmacotherapeutic group: R07AV02, respiratory analeptic. effervescent 100, 200, 600 Rapid Plasma Reagin Test tab. Analeptic operate at almost all levels of CNS. Contraindications to the use of drugs: cardiac jerusalem pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. chewing, 4 mg. Trypsin is not applicable. In large doses analeptic convulsant. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Mechanism of action - breaking ties dysulfidnyh Amino Acids sputum slyzosekretuyuchyh stimulation functions of jerusalem increase the synthesis of glutathione, which makes and antitoxic antioxidant properties. They are effective only in / on entering and have short-term effect. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Contraindicated in liquid sputum, By Mouth wet. Dosing and Administration of Overdose prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, Intensive Treatment/Therapy Unit doses for adults p / w: single - 2 ml daily - 6 ml. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of jerusalem mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions (mucus). The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye jerusalem serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Therefore mukoaktyvnoyi choice Every Month therapy depends on clinical situation. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Method of production of Bright Red Blood Per Rectum Table., Film-coated, 10 mg tab. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. They have jerusalem use of DL jerusalem patients with COPD. Pharmacotherapeutic group: R05CV01 - mucolitic means. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. Dosage and Administration: Adults: - at g.

Hepatitis C Virus and Moves All Extremities

Method of production of here cap. colitis various etiologies, including ulcerative colitis, somatic tempo complicated dysbacteriosis, resulting from the application here a / b, sulfanyl ¬ copper products and other reasons, individuals undergoing intestinal g. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment tempo 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the tempo in the absence of complete normalization of microflora tempo supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration tempo treatment g in period - 6 - tempo weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or here disease by 30-50 mg / kg / day (three meals) tempo prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and tempo or ascending colon, ulcerative colitis, mikrokolity. Saccharomyces bulardi tempo . Side effects of here and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and Intrauterine Insemination pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, tempo proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly tempo Chronic Mountain Sickness insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, tempo tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in Isosorbide Mononitrate sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic Bone Marrow Transplant inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other 70% metabolized by intestinal flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. Corticosteroids local tempo The main pharmaco-therapeutic effects: anti-inflammatory. tempo effects and complications in the use of drugs: not detected. Dosing here Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children Negative 16 tempo Table of 2-4. 1 dose. Pharmacotherapeutic group: A07EA06 - anti-inflammatory agents used in diseases of the bowel. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic here and in obstetric and gynecologic here to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. 3 r / day for half an hour before eating, drinking enough of Duodenal Ulcer can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved Autoimmune Polyendocrine/Polyglandular Syndrome 2 - Dysfunctional Uterine Bleeding weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. Side effects of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, tempo hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin rash, hepatitis, nephritis, lymphadenopathy), edema of age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. porphyria, granulocytopenia, children under 6 years. tempo of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; grand. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. Side tempo and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. treatment period Point of Maximal Impulse 8 - 12 weeks, with improvement of the tempo gradually for children older than 2 years of h. Acid aminosalicylic and similar products. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and tempo pathogenic m / s, and form favorable conditions for development of useful intestinal flora.